However, AITC is also associated with reduced inflammation in diseases such as osteoarthritis and inflammatory bowel disease, and like SF, this was conferred through the activation of TRPA1, ERK signaling, and the inhibition of monocyte MCP-1 [107,108,109]. Here, TRPA1 is linked to inflammatory bowel disease.